Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2026-03-01 @ 5:54 PM
Study NCT ID:
NCT00637832
Status:
TERMINATED
Last Update Posted:
2022-01-06
First Post:
2008-03-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma
Sponsor:
Organization: